EUS-guided local thermal ablation is a minimally invasive therapeutic approach increasingly applied in patients with pancreatic cancer and recently, a new experimental device, the HybridTherm probe (HTP), combining bipolar radiofrequency ablation and cryotherapy (currently not commercially available), has shown to be feasible and safe in patients with locally advanced pancreatic adenocarcinoma (PDAC). This is the case report of a 71-year-old man, with PDAC, treated by 2 ablative sessions with HTP under EUS guide during standard chemotherapy. The patient showed a good response (necrosis inside the lesion) to ablative therapy associated with chemotherapy and underwent respective surgery (Whipple pylorus preserving surgery; histology: ypT3N1,G2) and he is currently still alive after 1466 days and adjuvant chemotherapy, with a relapse along the superior mesenteric vein, 18 × 11 mm in size.
EUS-guided ablation with HybridTherm Probe / S.G.G. Testoni, G. Rossi, P.G. Arcidiacono - In: Atlas of Interventional EUS : Case-based Strategies / [a cura di] A.Y.B. Teoh, M. Giovaninni, M.A. Khashab, T. Itoi. - [s.l] : Springer Nature Singapore Pte Ltd., 2022. - ISBN 978-981-16-9339-7. - pp. 211-216 [10.1007/978-981-16-9340-3_42]
EUS-guided ablation with HybridTherm Probe
S.G.G. TestoniPrimo
;
2022
Abstract
EUS-guided local thermal ablation is a minimally invasive therapeutic approach increasingly applied in patients with pancreatic cancer and recently, a new experimental device, the HybridTherm probe (HTP), combining bipolar radiofrequency ablation and cryotherapy (currently not commercially available), has shown to be feasible and safe in patients with locally advanced pancreatic adenocarcinoma (PDAC). This is the case report of a 71-year-old man, with PDAC, treated by 2 ablative sessions with HTP under EUS guide during standard chemotherapy. The patient showed a good response (necrosis inside the lesion) to ablative therapy associated with chemotherapy and underwent respective surgery (Whipple pylorus preserving surgery; histology: ypT3N1,G2) and he is currently still alive after 1466 days and adjuvant chemotherapy, with a relapse along the superior mesenteric vein, 18 × 11 mm in size.
| File | Dimensione | Formato | |
|---|---|---|---|
|
EUS guided HybridTherm Probe ablation Atlas of Interventional EUS 2022.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
2.33 MB
Formato
Adobe PDF
|
2.33 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
